Emergent Biosolutions (EBS) has an orphaned factory in Baltimore, capable of churning out a billion doses of J&J and AstraZeneca vaccine every year. I had written good things about it in passing a couple of months ago when the stock was trading at a (then) low of $80 or so. But as fate would have it, trying to handle manufacturing for both J&J and AZ turned out to be a problem for Emergent. Contamination became rife and employees literally ended up
Emergent (EBS), J&J and Chikungunya
Emergent (EBS), J&J and Chikungunya
Emergent (EBS), J&J and Chikungunya
Emergent Biosolutions (EBS) has an orphaned factory in Baltimore, capable of churning out a billion doses of J&J and AstraZeneca vaccine every year. I had written good things about it in passing a couple of months ago when the stock was trading at a (then) low of $80 or so. But as fate would have it, trying to handle manufacturing for both J&J and AZ turned out to be a problem for Emergent. Contamination became rife and employees literally ended up